Federal News
NIH Awards $265M for Human-Based Research Methods
March 19, 2026
The National Institutes of Health (NIH) has awarded a combined total of $265 million under the Complement Animal Research in Experimentation (Complement-ARIE) program to develop and standardize human-based research methods (New Approach Methodologies, NAMs) aimed at reducing reliance on animal models. These awards, announced on March 18, 2026, support the establishment of technology development centers, a data hub, and a validation network to accelerate regulatory acceptance and clinical translation of more predictive human disease models. Additionally, NIH, in partnership with the FDA and EPA, is investing $7 million in a Reduction to Practice Challenge to demonstrate the viability of these NAMs within three years.
- Why this matters: This significant federal investment signals a strategic shift toward human-relevant research models, creating procurement opportunities for technology developers, research institutions, and service providers specializing in NAMs.
- Agencies and contractors should prepare for collaborative projects involving multi-agency partnerships (NIH, FDA, EPA) focused on technology development, data integration, and validation efforts.
- Organizations can leverage this funding to align offerings with regulatory acceptance pathways, enhancing market readiness and adoption of NAMs.
- Procurement professionals should note the emphasis on standardization and validation infrastructure, indicating potential solicitations for data management, technology platforms, and research services based in Bethesda, Maryland.
Agencies
National Institutes of Health, U.S. Food and Drug Administration, Environmental Protection Agency, Foundation for the National Institutes of Health, U.S. Department of Health and Human Services
Contracts
$265 million, $7 million